COM:VISTAGEN
Vistagen Therapeutics, Inc
- Stock
Last Close
2.53
22/11 21:00
Market Cap
71.84M
Beta: -
Volume Today
266.16K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 15.60K - | 15.60K 0% | 115.20K - | 115.20K 0% | 471.10K 308.94% | 1.70M 260.35% | 858.70K 49.42% | -367.80K 142.83% | ||||
average payables | 1.90M - | 2.35M 23.63% | 1.59M 32.12% | 901.65K 43.42% | 1.03M 14.40% | 1.13M 9.10% | 1.45M 28.48% | 1.34M 7.49% | 1.80M 34.47% | 2.62M 45.45% | 2.01M 23.16% | |
average receivables | 1.40K - | 1.40K 0% | 150K - | 150K 0% | 20.30K 86.47% | 189.25K 832.27% | 570.30K 201.35% | 401.35K 29.62% | ||||
book value per share | -349.49 - | -467.31 33.71% | -50.52 89.19% | 2.45 104.86% | 14.94 509.03% | 7.43 50.25% | -3.92 152.72% | 32.04 917.65% | 0.33 98.98% | 0.00 99.47% | 0.01 240.15% | |
capex per share | -0.26 - | -0.45 - | -0.95 113.40% | -0.00 99.64% | -0.18 5,188.55% | -0.10 - | -0.00 98.94% | -0.00 96.99% | -0.00 89.65% | |||
capex to depreciation | -0.18 - | -0.49 - | -4.36 785.94% | -0.02 99.54% | -1.91 9,522.94% | -2.34 - | -0.28 87.97% | -0.40 41.62% | -0.11 73.09% | |||
capex to operating cash flow | 0.00 - | 0.01 - | 0.03 501.96% | 0.00 99.46% | 0.01 6,680.86% | 0.02 - | 0.00 80.59% | 0.00 3.70% | 0.00 44.58% | |||
capex to revenue | -0.19 - | -0.25 - | -0.18 28.51% | 0.93 616.10% | -0.06 106.15% | |||||||
cash per share | -0.16 - | 1.59 1,071.97% | 7.27 356.63% | 11.64 60.03% | 22.42 92.64% | 13.76 38.61% | 0.93 93.27% | 35.91 3,775.36% | 0.34 99.04% | 0.00 99.31% | 0.01 157.52% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 13.60 - | 111.22 717.71% | -1.29K 1,258.93% | |||||||||
debt to assets | 26.24 - | 52.89 101.56% | 0.07 99.86% | 0.02 74.37% | 0.01 68.66% | 0.00 18.53% | 0.71 14,813.59% | 0.03 95.16% | 0.04 18.54% | 0.13 216.80% | 0.02 86.71% | |
debt to equity | -0.54 - | -0.69 28.44% | -0.02 96.52% | 0.11 564.64% | 0.01 91.52% | 0.01 1.05% | -0.71 7,686.99% | 0.04 105.66% | 0.05 16.14% | 0.23 379.50% | 0.02 91.76% | |
dividend yield | 85.15 - | 79.77 6.32% | 30.01 62.38% | 65.46 118.16% | 7.55 88.46% | 0.13 98.30% | 0.03 73.03% | |||||
earnings yield | -0.29 - | -1.05 258.63% | -3.05 189.91% | -0.69 77.24% | -1.11 59.86% | -0.65 41.71% | -1.08 66.26% | -0.10 90.92% | -0.01 93.37% | -0.00 63.53% | -0.00 88.12% | |
enterprise value | 17.03M - | 27.38M 60.75% | 15.11M 44.81% | 11.91M 21.19% | 2.61M 78.13% | 24.95M 857.86% | 22.04M 11.68% | 84.07M 281.48% | 7.30B 8,582.38% | 25.04B 242.99% | 104.40B 316.96% | |
enterprise value over ebitda | -3.43 - | -4.00 16.54% | -0.85 78.77% | -1.17 37.61% | -0.18 84.30% | -1.02 456.53% | -1.07 4.51% | -4.72 342.60% | -155.92 3,201.34% | -422.45 170.93% | -3.16K 648.39% | |
ev to operating cash flow | -8.01 - | -9.89 23.43% | -3.14 68.22% | -1.64 47.82% | -0.29 82.46% | -1.72 497.25% | -1.40 18.57% | -6.96 397.86% | -161.30 2,216.28% | -503.62 212.23% | -4.04K 703.06% | |
ev to sales | 9.53 - | 77.17 - | 6.58K 8,430.49% | -110.15K 1,773.32% | 98.12K 189.07% | |||||||
free cash flow per share | -58.31 - | -62.99 8.02% | -82.04 30.25% | -29.88 63.58% | -19.57 34.51% | -15.44 21.09% | -10.78 30.22% | -4.30 60.08% | -0.23 94.66% | -0.01 96.88% | -0.00 81.37% | |
free cash flow yield | -0.21 - | -0.21 0.62% | -0.31 48.86% | -0.51 62.59% | -0.70 38.02% | -0.39 44.82% | -0.82 110.93% | -0.07 91.75% | -0.01 90.83% | -0.00 67.71% | -0.00 87.58% | |
graham net net | -356.38 - | -471.85 32.40% | -60.04 87.27% | -0.70 98.84% | 12.99 1,963.16% | 6.83 47.43% | -6.94 201.57% | 30.41 538.25% | 0.30 99.01% | 0.00 99.63% | 0.01 402.09% | |
graham number | 798.25 - | 1.82K 128.30% | 954.37 47.63% | 47.48 95.02% | 102.05 114.93% | 65.71 35.61% | 35.39 46.15% | 67.10 89.61% | 1.33 98.01% | 0.02 98.63% | 0.01 22.15% | |
income quality | 0.72 - | 0.20 72.16% | 0.10 48.93% | 0.71 595.39% | 0.63 10.83% | 0.59 6.43% | 0.76 28.38% | 0.67 11.24% | 0.95 40.75% | 0.84 11.44% | 0.88 4.77% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -3.22 - | -1.47 54.41% | -22.97 1,465.09% | -2.05K 8,822.12% | -1.60K 22.16% | 3.07 100.19% | -1.39K 45,278.36% | -1.38K 0.52% | -205.94 85.07% | -2.58K 1,151.25% | ||
interest debt per share | 231.57 - | 429.49 85.47% | 14.40 96.65% | 0.30 97.95% | 0.16 45.34% | -8.33 5,264.71% | 2.81 133.70% | 1.30 53.72% | 0.02 98.73% | 0.00 97.61% | 0.00 72.21% | |
inventory turnover | ||||||||||||
invested capital | -0.54 - | -0.69 28.44% | -0.02 96.52% | 0.11 564.64% | 0.01 91.52% | 0.01 1.05% | -0.71 7,686.99% | 0.04 105.66% | 0.05 16.14% | 0.23 379.50% | 0.02 91.76% | |
market cap | 10.11M - | 13.19M 30.47% | 15.47M 17.30% | 14.76M 4.57% | 12.92M 12.49% | 37.99M 194.08% | 19.30M 49.19% | 183.46M 850.47% | 7.36B 3,914.29% | 25.05B 240.15% | 104.51B 317.20% | |
net current asset value | -13.02M - | -20.71M 59.00% | -3.11M 84.97% | 281.50K 109.05% | 6.66M 2,266.39% | 6.71M 0.80% | -9.92M 247.76% | 87.81M 985.09% | 61.07M 30.46% | 8.50M 86.08% | 111.31M 1,209.75% | |
net debt to ebitda | -1.40 - | -2.07 48.58% | 0.02 100.97% | 0.28 1,296.62% | 0.73 159.55% | 0.53 26.57% | -0.13 124.85% | 5.58 4,313.66% | 1.39 75.10% | 0.23 83.11% | 3.54 1,409.44% | |
net income per share | -81.03 - | -315.87 289.82% | -801.28 153.67% | -40.85 94.90% | -30.98 24.15% | -25.83 16.65% | -14.21 45.00% | -6.25 56.03% | -0.24 96.14% | -0.01 96.47% | -0.00 82.18% | |
operating cash flow per share | -58.05 - | -62.99 8.51% | -81.60 29.54% | -28.93 64.55% | -19.56 32.37% | -15.26 22.01% | -10.78 29.38% | -4.21 60.97% | -0.23 94.56% | -0.01 96.87% | -0.00 81.33% | |
payables turnover | ||||||||||||
receivables turnover | 26.83 - | 3.28 87.77% | -0.28 108.63% | |||||||||
research and ddevelopement to revenue | 4.16 - | 11.45 - | 31.93 178.83% | -195.24 711.44% | 18.82 109.64% | |||||||
return on tangible assets | -11.25 - | -51.49 357.49% | -47.71 7.34% | -2.76 94.21% | -1.27 53.96% | -1.75 37.97% | -3.60 105.07% | -0.17 95.40% | -0.64 286.34% | -2.81 339.05% | -0.24 91.55% | |
revenue per share | 4.98 - | 0.38 - | 0.01 98.52% | -0.00 100.58% | 0.00 268.30% | |||||||
roe | 0.23 - | 0.68 191.54% | 15.86 2,246.45% | -16.65 205.00% | -2.07 87.55% | -3.48 67.56% | 3.63 204.33% | -0.19 105.38% | -0.74 278.52% | -4.90 564.55% | -0.26 94.76% | |
roic | 0.86 - | 1.08 26.03% | 6.15 469.24% | -14.66 338.52% | -2.03 86.15% | -3.43 69.13% | -8.68 152.65% | -0.18 97.92% | -0.67 274.11% | -3.40 404.29% | -0.28 91.67% | |
sales general and administrative to revenue | 4.69 - | 6.01 - | 9.43 56.85% | -64.51 784.44% | 13.22 120.49% | |||||||
shareholders equity per share | -349.49 - | -467.31 33.71% | -50.52 89.19% | 2.45 104.86% | 14.94 509.03% | 7.43 50.25% | -3.92 152.72% | 32.04 917.65% | 0.33 98.98% | 0.00 99.47% | 0.01 240.15% | |
stock based compensation to revenue | 0.68 - | 2.12 - | 3.14 48.29% | -14.68 567.63% | 2.05 113.97% | |||||||
tangible asset value | -12.80M - | -20.54M 60.49% | -2.98M 85.51% | 615.80K 120.68% | 6.92M 1,023.19% | 7.08M 2.29% | -5.73M 180.98% | 91.98M 1,705.38% | 64.72M 29.64% | 12.08M 81.33% | 114.29M 846.08% | |
tangible book value per share | -349.49 - | -467.31 33.71% | -50.52 89.19% | 2.45 104.86% | 14.94 509.03% | 7.43 50.25% | -3.92 152.72% | 32.04 917.65% | 0.33 98.98% | 0.00 99.47% | 0.01 240.15% | |
working capital | -5.17M - | -17.28M 234.59% | -939.40K 94.56% | 2.01M 314.01% | 9.56M 375.76% | 10.85M 13.44% | -1.19M 110.98% | 99.93M 8,489.60% | 65.23M 34.72% | 12.94M 80.16% | 115.55M 792.96% |
All numbers in (except ratios and percentages)